Computing Resources: Difference between revisions
Jump to navigation
Jump to search
(MRD) |
(totals) |
||
Line 22: | Line 22: | ||
| RNASeq || Drug Screening || Leukemia Biology || || || || style="text-align:right;" |0.4 || | | RNASeq || Drug Screening || Leukemia Biology || || || || style="text-align:right;" |0.4 || | ||
|- | |- | ||
| Total || || || style="text-align:right;" |4 || style="text-align:right;" | | | Total || || || style="text-align:right;" |4.05 || style="text-align:right;" |0.07 || style="text-align:right;" |15.2 || style="text-align:right;" |26.3 || | ||
|- | |- | ||
|} | |} |
Revision as of 19:35, 15 April 2024
Type of Data | Project | Lab | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
MRD | Routine | Molecular Biology | 0.05 | 0.07 | 0.20 | 0.30 | 0.40 |
Exome | Precision Medicine | Epigenomics | |||||
ctDNA | Circular Tumoral DNA | Molecular Biology | |||||
Methylome | Precision Medicine | Epigenomics | |||||
Mass spectra | DESI | Leukemia Biology / Pathology | 4 | - | - | - | - |
Imaging | Drug Screening | Leukemia Biology | 15 | 25 | |||
Panel | Drug Screening | Leukemia Biology | 0.4 | ||||
Methylome | Drug Screening | Leukemia Biology | 0.03 | ||||
RNASeq | Drug Screening | Leukemia Biology | 0.4 | ||||
Total | 4.05 | 0.07 | 15.2 | 26.3 |